ConductScience.org, home

Paper41279441

mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria.

Hassert M and 8 others. bioRxiv, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria. Papers, record 41279441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41279441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
mRNA vaccination overcomes hemozoin-mediated impairment of whole parasite vaccine efficacy for malaria.
PubMed
Journal
bioRxiv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-18
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hassert MMariahhttps://orcid.org/0000-0002-2141-3344
2Drewry LLLisa L
3Pewe LLLecia L
4Hancox LSLisa S
5He RRui
6Arumugam SSahaana
7Mix MRMadison R
8Salem AKAliasger K
9Harty JTJohn T

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants19

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 EY034198NEI NIH HHSUnited StatesR21EY034198PubMed and NIHNIH RePORTER
T32 AI007260NIAID NIH HHSUnited StatesT32AI007260PubMed and NIHNIH RePORTER
R01 AI100527NIAID NIH HHSUnited StatesR01AI100527PubMed and NIHNIH RePORTER
P30 ES005605NIEHS NIH HHSUnited StatesP30ES005605PubMed and NIHNIH RePORTER
T32 GM139776NIGMS NIH HHSUnited StatesT32GM139776PubMed and NIHNIH RePORTER
R01 AI167847NIAID NIH HHSUnited StatesR01AI167847PubMed and NIHNIH RePORTER
K99 AI190129NIAID NIH HHSUnited StatesK99AI190129PubMed and NIHNIH RePORTER
R21 AI042767NIAID NIH HHSUnited StatesR01AI042767PubMed and NIHNIH RePORTER
R01 AI114543NIAID NIH HHSUnited StatesR01AI114543PubMed and NIHNIH RePORTER
F32 AI167088NIAID NIH HHSUnited StatesF32AI167088PubMed and NIHNIH RePORTER
R37 AI042767NIAID NIH HHSUnited StatesR01AI042767PubMed and NIHNIH RePORTER
F32 AI174382NIAID NIH HHSUnited StatesF32AI174382PubMed and NIHNIH RePORTER
P30 CA086862NCI NIH HHSUnited StatesP30CA086862PubMed and NIHNIH RePORTER
R01 AI042767NIAID NIH HHSUnited StatesR01AI042767PubMed and NIHNIH RePORTER
R21 ES032937NIEHS NIH HHSUnited StatesR21ES032937PubMed and NIHNIH RePORTER
R21 DE031042NIDCR NIH HHSUnited StatesR21DE031042PubMed and NIHNIH RePORTER
R01 AI185725NIAID NIH HHSUnited StatesR01AI185725PubMed and NIHNIH RePORTER
R21AI042767NIHNIH RePORTER
R37AI042767NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Updated in41629565mRNA vaccination overcomes haemozoin-mediated impairment of whole-parasite malaria vaccines in mice.https://conductscience.org/library/papers/41629565

Source PubMed

Download CSV of comments and corrections

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130127085Prime-and-Trap Malaria Vaccination To Generate Protective CD8+ Liver-Resident Memory T Cells.J Immunol2018https://conductscience.org/library/papers/30127085PubMed
231300331Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.Lancet Infect Dis2019https://conductscience.org/library/papers/31300331PubMed
310762410Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection.Immunol Cell Biol2000https://conductscience.org/library/papers/10762410PubMed
433674759COVID-19 vaccines: modes of immune activation and future challenges.Nat Rev Immunol2021https://conductscience.org/library/papers/33674759PubMed
532714882Plasmodium Impairs Antibacterial Innate Immunity to Systemic Infections in Part Through Hemozoin-Bound Bioactive Molecules.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/32714882PubMed
610903750The complexity of protective immunity against liver-stage malaria.J Immunol2000https://conductscience.org/library/papers/10903750PubMed
723937890The hemozoin conundrum: is malaria pigment immune-activating, inhibiting, or simply a bystander?Trends Parasitol2013https://conductscience.org/library/papers/23937890PubMed
822567535In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice.Malar Res Treat2012https://conductscience.org/library/papers/22567535PubMed
923907956Immunopathological effects of malaria pigment or hemozoin and other crystals.Biofactors2014https://conductscience.org/library/papers/23907956PubMed
1027262417Malaria vaccines and human immune responses.Curr Opin Microbiol2016https://conductscience.org/library/papers/27262417PubMed
1126858424Composition of the gut microbiota modulates the severity of malaria.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26858424PubMed
1235096512Hemozoin: a Complex Molecule with Complex Activities.Curr Clin Microbiol Rep2021https://conductscience.org/library/papers/35096512PubMed
1315630134Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin.J Exp Med2005https://conductscience.org/library/papers/15630134PubMed
1424825778Correlates of protective immunity following whole sporozoite vaccination against malaria.Immunol Res2014https://conductscience.org/library/papers/24825778PubMed
1527084099Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.J Immunol2016https://conductscience.org/library/papers/27084099PubMed
1636159849Five decades of clinical assessment of whole-sporozoite malaria vaccines.Front Immunol2022https://conductscience.org/library/papers/36159849PubMed
1737474653mRNA vaccine against malaria tailored for liver-resident memory T cells.Nat Immunol2023https://conductscience.org/library/papers/37474653PubMed
1832566259Malaria vaccines since 2000: progress, priorities, products.NPJ Vaccines2020https://conductscience.org/library/papers/32566259PubMed
1910432044A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum.Am J Trop Med Hyg1999https://conductscience.org/library/papers/10432044PubMed
2017261807Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17261807PubMed

See all 74 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41279441

GET https://conductscience.org/api/papers/v1/41279441/references?page=2